Biofrontera
BFRIW
6 hedge funds and large institutions have $4.67K invested in Biofrontera in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.1% less ownership
Funds ownership: 4.01% → 3.91% (-0.1%)
36% less capital invested
Capital invested by funds: $7.27K → $4.67K (-$2.59K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$233 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$4 |
| 3 |
CS
Clear Street
New York
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$465 |
BFRIW Hedge Fund Activity: Q3 2024 in Review
6 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q3 2024, worth a combined $4.67K — down 36% from $7.27K a quarter earlier.
Fund positioning in BFRIW was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $233. The largest seller was Citadel Advisors, exiting entirely with an estimated $465 sold.
- 6 institutional investors held Biofrontera (BFRIW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $4.67K of Biofrontera stock for Q3 2024, down 36% quarter-over-quarter.
- 1 fund opened new Biofrontera positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest Biofrontera buyer in Q3 2024 was UBS Group, an estimated $233 added.
- The largest Biofrontera seller in Q3 2024 was Citadel Advisors, an estimated $465 sold.
Based on aggregated 13F filings for Q3 2024.